These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 27099933

  • 1. Clinicopathological and prognostic significance of Nestin expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
    Li S, Lai Y, Fan J, Shen C, Che G.
    Clin Exp Med; 2017 May; 17(2):161-174. PubMed ID: 27099933
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological and prognostic significance of Oct-4 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
    Li SJ, Huang J, Zhou XD, Zhang WB, Lai YT, Che GW.
    J Thorac Dis; 2016 Jul; 8(7):1587-600. PubMed ID: 27499947
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Li S, Wang Z, Huang J, Cheng S, Du H, Che G, Peng Y.
    BMC Cancer; 2016 Nov 11; 16(1):877. PubMed ID: 27835987
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis.
    Min SH, Zheng QQ.
    Medicine (Baltimore); 2021 Nov 24; 100(47):e27919. PubMed ID: 34964763
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathological and prognostic significance of heat shock protein 27 (HSP27) expression in non-small cell lung cancer: a systematic review and meta-analysis.
    Li S, Zhang W, Fan J, Lai Y, Che G.
    Springerplus; 2016 Nov 24; 5(1):1165. PubMed ID: 27512624
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of TGF-β in lung cancer: systematic review and meta-analysis.
    Li J, Shen C, Wang X, Lai Y, Zhou K, Li P, Liu L, Che G.
    BMC Cancer; 2019 Jul 15; 19(1):691. PubMed ID: 31307405
    [Abstract] [Full Text] [Related]

  • 7. Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis.
    Li Q, Liu F, Zhang Y, Fu L, Wang C, Chen X, Guan S, Meng X.
    Oncotarget; 2016 Jun 07; 7(23):34520-31. PubMed ID: 27150062
    [Abstract] [Full Text] [Related]

  • 8. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
    Liu Q, Li A, Tian Y, Liu Y, Li T, Zhang C, Wu JD, Han X, Wu K.
    J Hematol Oncol; 2016 Nov 08; 9(1):119. PubMed ID: 27821176
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
    Zhang J, Gu Y, Liu X, Rao X, Huang G, Ouyang Y.
    Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 32696952
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
    Luo Z, Wu RR, Lv L, Li P, Zhang LY, Hao QL, Li W.
    Int J Clin Exp Pathol; 2014 Jul 31; 7(7):3632-46. PubMed ID: 25120740
    [Abstract] [Full Text] [Related]

  • 11. Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis.
    Hu L, Zhang P, Mei Q, Sun W, Zhou L, Yin T.
    BMC Cancer; 2020 May 14; 20(1):424. PubMed ID: 32408907
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis.
    Yang T, Hao L, Yang X, Luo C, Wang G, Lin Cai C, Qi S, Li Z.
    BMJ Open; 2021 Sep 02; 11(9):e049123. PubMed ID: 34475167
    [Abstract] [Full Text] [Related]

  • 13. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
    Zhao S, Qiu Z, He J, Li L, Li W.
    Int J Clin Exp Pathol; 2014 Sep 02; 7(10):6694-704. PubMed ID: 25400749
    [Abstract] [Full Text] [Related]

  • 14. Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases.
    Ye Z, Zhang X, Luo Y, Li S, Huang L, Li Z, Li P, Chen G.
    PLoS One; 2016 Sep 02; 11(9):e0163162. PubMed ID: 27657690
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
    Zhu L, Yu H, Liu SY, Xiao XS, Dong WH, Chen YN, Xu W, Zhu T.
    PLoS One; 2015 Sep 02; 10(4):e0124230. PubMed ID: 25905787
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers.
    Ryuge S, Sato Y, Nagashio R, Hiyoshi Y, Katono K, Igawa S, Nakashima H, Shiomi K, Ichinoe M, Murakumo Y, Saegusa M, Satoh Y, Masuda N.
    PLoS One; 2017 Sep 02; 12(3):e0173886. PubMed ID: 28358810
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.